Login / Signup

Availability and pricing of insulin and related diagnostics in South Africa.

Samirah BayatVelisha Ann Perumal-PillayFatima Suleman
Published in: Journal of pharmaceutical policy and practice (2024)
Overall, there is a good availability of insulin and related diagnostics in SA. Even though insulin is cheaper than other countries, it is unaffordable to the LPGW. This highlights the importance of ensuring a constant availability of insulin in the free public sector. Whilst human insulins are cheaper than newer analogue insulins and SA faces cost constraints, important variables in favour of newer insulins, such as ease-of-use, long term outcomes and value should be considered when treatment guidelines are updated. Annual POC testing should be available and offered free to all patients to detect diabetes early.
Keyphrases